Achillion Pharmaceuticals reports that Brian Di Donato, Chief Financial Officer, and Steven Zelenkofske, D.O., Chief Medical Officer, will present at the JMP Securities Life Sciences Conference on June 20 at the St. Regis New York … more
Separately, Achillion reports that the final data set for ACH-4471 (newly designated “danicopan”) proof of concept Phase 2 trial in untreated patients with paroxysmal nocturnal hemoglobinuria (PNH) was accepted for oral presentation at the 24thCongress of the European Hematology Association … more